DEC 10, 2015 1:12 PM PST

Cell Division Enzyme Plays Dual Role in Inflammatory Pathway

WRITTEN BY: Kara Marker
The NEK7 enzyme has been completely characterized for its role in innate immunity, however until this discovery was made and the study published, scientists were only aware of its role in cell division. In fact, this enzyme also performs a “switch-like” activity that affects inflammation.

NEK7 comes from a family of NIMA-related kinases, a group the controls the initiation of mitosis (Genecards.org). This week, in a study published in Nature Immunology, scientists from UT Southwestern Medical Center (UTSMC) showed that NEK7 also plays a role in the NLRP3 inflammasome pathway, a series of actions studied and revealed in 2014 to activate inflammatory particles to be released from macrophages during a microbial invasion (Nature Immunology).
regulation of the NLRP3 inflammasome pathway

In the UTSMC study, scientists observed mouse models of inflammatory bowel disease and multiple sclerosis, looking to make a connection between NEK7 defects and NLRP3 errors. After extensive genetic screening, NEK7 mutations were clearly linked to NLRP3 defects, and the scientists were able to fully characterize the role of NEK7 in the NLRP3 inflammasome pathway.

Since this pathway activates cytokines that trigger inflammation in response to invading organisms, identifying NEK7 as a component of NLRP3, NEK7’s newly discovered connection to inflammation is thought to have potential for treating medical conditions linked to inflammation.
 
As regulators of mitosis, it makes sense that NIMA-related kinases should be linked to inflammation, and their identifying acronym quite literally means “never in mitosis” (Genecards.org).

“Our work has shown that the inflammasome cannot become activated during mitosis,” said Dr. Bruce Beutler, Director of the Center for the Genetics of Host Defense at UT Southwestern and senior author of the study. He and other researchers speculate that this is designed to protect the dividing cell from DNA damage.


Source: UT Southwestern Medical Center
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 17, 2020
Immunology
COVID Vaccine Works in Macaques - What about in Humans?
SEP 17, 2020
COVID Vaccine Works in Macaques - What about in Humans?
Pharmaceutical giant Pfizer, in partnership with BioNTech has reported that one of its lead vaccine candidates has shown ...
SEP 17, 2020
Coronavirus
A Biomarker May Predict the Most Severe COVID-19 Cases
SEP 17, 2020
A Biomarker May Predict the Most Severe COVID-19 Cases
Researchers may have found a way to identify the COVID-19 patients that will need targeted therapies the most.
OCT 15, 2020
Immunology
The Immune Cells Giving Menopausal Women Higher BPs
OCT 15, 2020
The Immune Cells Giving Menopausal Women Higher BPs
In general, men have higher blood pressures than women, giving them an increased risk of developing heart disease. After ...
OCT 26, 2020
Immunology
Gearing up for Life: The First 7 Days of the Immune System
OCT 26, 2020
Gearing up for Life: The First 7 Days of the Immune System
The mother’s placenta serves as a shield for the developing fetus inside the womb, protecting it from the constant ...
NOV 24, 2020
Immunology
Dirty Sheets Make Babies Healthier
NOV 24, 2020
Dirty Sheets Make Babies Healthier
Microbiologists have established that the development of infants’ immune systems is intricately linked to the dive ...
NOV 25, 2020
Immunology
Another COVID-19 vaccine shows promising results!
NOV 25, 2020
Another COVID-19 vaccine shows promising results!
A week ago, another biotechnology company "Moderna" announced the preliminary results from its COVID-19 vaccin ...
Loading Comments...